MiraVista Diagnostics Revenue and Competitors

Claim your profile

Indianapolis, IN USA



Total Funding

Estimated Revenue & Valuation

  • MiraVista Diagnostics's estimated annual revenue is currently $14.6M per year.(i)
  • MiraVista Diagnostics's estimated revenue per employee is $189,351

Employee Data

  • MiraVista Diagnostics has 77 Employees.(i)
  • MiraVista Diagnostics grew their employee count by 18% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

MiraVista Diagnostics is a CLIA and CAP certified reference laboratory with an exclusive focus on developing and processing diagnostic tests for serious fungal infection. The company was founded in 2002 by the renowned infectious disease scientist, Dr. Lawrence Joseph Wheat, whose groundbreaking research contributions resulted in the development of the first Histoplasma antigen test. Today, MiraVista Diagnostics serves the medical and veterinary sectors in the U.S. and Canada processing over 125,000 tests per year for fungal infections. This includes antigen and antibody detection tests for Coccidioides (Valley Fever), Aspergillus, Histoplasma capsulatum, Blastomyces dermatitidis, Beta-D Glucan and Cryptococcus. The company offers same-day testing, prompt response time, and direct access to the laboratory’s team of experienced infectious disease specialists that has collectively published nearly 1,000 scientific articles. MiraVista Diagnostics' customers include large medical research hospitals, health care institutions and universities as well as national reference labs and veterinary clinics. Visit www.MiraVistaLabs.com or call 866.647.2847 to discuss a fungal infection case, set up a corporate account for high volume testing or order from among MiraVista’s menu of diagnostic tests for serious fungal diseases.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding